Todays approval is another demonstration of what the FDA can accomplish when we try bold new things. The higher-dose GLP-1 is indicated to reduce excess body weight and maintain weight reduction long-term in adults with obesity, or overweight with at least one weight-related condition, per the FDAs statement
Semaglutide does not directly affect intrinsic factor production, but the reduced stomach acid environment can compromise the initial separation step that makes b12 available for intrinsic factor binding
I cant say enough about my overall experience with Optimize U
Semaglutide Side Effects and Safety Semaglutide is generally well tolerated, with the most common side effects being nausea, mild vomiting, diarrhea, or constipation particularly during the early dose escalation phase
Clearfield, a leading authority on cutting-edge medicine is a prolific and popular speaker regularly addressing the Age Management Medical Group, the American Academy of Anti-Aging Medicine, OMED, the American Osteopathic Associations Scientific Convention, the Nevada Osteopathic Association, the American Osteopathic Society of Rheumatologic Disease, SVYASA University in Bengaluru, India, and the Second through Eighth Annual Global Webinars on Traditional and Alternative Medicine
